BATBC Plans $24 Million Investment to Boost Cigarette Production

BAT by 2FIRSTS.ai
Dec.27.2024
BATBC Plans $24 Million Investment to Boost Cigarette Production
BATBC plans to invest 2.838 billion Taka to boost cigarette production capacity, satisfying growing demand, Financial Express reported.

According to The Financial Express on December 27th, British American Tobacco Bangladesh Company (referred to as "BATBC") plans to invest 2.838 billion Taka (240 million USD) to increase its production capacity to meet the growing demand for cigarettes. This fund will be used for purchasing, converting knitting, inspecting, installing, spare parts, and transferring machinery.


The company announced on Thursday (the 26th) in a stock exchange filing that its board of directors had approved the capital investment decision at a meeting the previous day. BATBC stated, "The investment will be made using internal funds and bank financing based on the company's cash flow.


British American Tobacco Bangladesh Company (BATBC) did not provide specific details about how much production capacity will increase or the exact impact on revenue and profits. Over the past four years, British American Tobacco has invested over 12 billion taka (1 billion USD) in stages to enhance production capacity.


In the nine months ending in September, the company's net sales increased by 2.12% year-on-year to reach 69.4 billion taka (6 billion USD), while profits slightly decreased by 2.5% to reach 13.22 billion taka (approximately 1 billion USD). Annual profits for 2023 were 17.88 billion taka (1.5 billion USD), remaining nearly flat compared to the previous year.


Notice

1. This article is provided exclusively for professional research purposes related to industry, technology and policy. Any reference to brands or products is made solely for the purpose of objective description and does not constitute an endorsement, recommendation, or promotion of any brand or product.

2. The use of nicotine products, including but not limited to cigarettes, e-cigarettes, and heated tobacco products, is associated with significant health risks. Users are required to comply with all relevant laws and regulations in their respective jurisdictions.

3. This article is strictly restricted from being accessed or viewed by individuals under the legal age.

Copyright

This article is either an original work by 2Firsts or a reproduction from third-party sources with the original source clearly indicated. The copyright and usage rights of this article belong to 2Firsts or the original source. Unauthorized reproduction, distribution, or any other unauthorized use of this article by any entity or individual is strictly prohibited. Violators will be held legally responsible. For copyright-related matters, please contact: info@2firsts.com

AI Assistance Disclaimer

This article may have utilized AI to enhance translation and editing efficiency. However, due to technical limitations, errors may occur. Readers are advised to refer to the sources provided for more accurate information.

This article should not be used as a basis for any investment decisions or advice, and 2Firsts assumes no direct or indirect liability for any errors in the content.

FDA Embraces AI: Generative System to Be Fully Operational by June's End
FDA Embraces AI: Generative System to Be Fully Operational by June's End
FDA plans to fully integrate a generative AI system across its centers by June 30, 2025. This follows the successful completion of an initial pilot, marking a shift in the agency's approach to regulatory processes. The AI tools are expected to streamline the drug approval process, which typically takes six to ten months, by reducing time spent on repetitive tasks.
May.09 by 2FIRSTS.ai
RELX Technology Q1 2025 Financial Report: Revenue Rises 46.5% YoY to $110 Million, Slips 0.6% from Previous Quarter
RELX Technology Q1 2025 Financial Report: Revenue Rises 46.5% YoY to $110 Million, Slips 0.6% from Previous Quarter
RELX Technology reported net revenue of RMB 810 million (US $110 million) for Q1 2025, down 0.6% quarter-over-quarter but up 46.5% year-over-year. On a non-GAAP basis, adjusted net profit for the quarter was RMB 250 million (US $34.6 million), a 0.2% decrease from the previous quarter and a 21.0% increase from a year earlier.
May.16 by 2FIRSTS.ai
VEEV Shifts UK Strategy: Discontinues Disposables, Rolls Out 32 Pod-Based SKUs In May
VEEV Shifts UK Strategy: Discontinues Disposables, Rolls Out 32 Pod-Based SKUs In May
VEEV, a PMI vaping brand, listed 32 new SKUs with the UK MHRA in May 2025, including VEEV ONE and ONE SE devices and 30 pod flavors. Its UK website shows the VEEV NOW disposable is discontinued, with the VEEV ONE series now available on the market.
May.20 by 2FIRSTS.ai
U.S. FDA Unveils AI Tool Elsa for Clinical Review, Internal Writing, and Data Processing
U.S. FDA Unveils AI Tool Elsa for Clinical Review, Internal Writing, and Data Processing
The U.S. Food and Drug Administration has officially launched Elsa, a generative AI tool designed to speed up clinical reviews, internal writing, and data processing tasks. After successful pilots across multiple departments, Elsa is now being rolled out agency-wide.
Jun.04 by 2FIRSTS.ai
Ispire Clarifies: Malaysia Plant Does Not Involve Nicotine or Cannabis Products, All Production for Export Only
Ispire Clarifies: Malaysia Plant Does Not Involve Nicotine or Cannabis Products, All Production for Export Only
Ispire stated that its Malaysia facility complies with local laws and only produces semi-finished vaporizer hardware without nicotine or cannabis. All products are for export and not distributed or sold in the local market.
Jun.10 by 2FIRSTS.ai
Thailand Offers $90 Bounty for Illegal E-Cigarette Reports
Thailand Offers $90 Bounty for Illegal E-Cigarette Reports
Thailand has launched a public enforcement initiative offering cash rewards of up to $90 for reporting illegal e-cigarette use or sales.
Apr.23 by 2FIRSTS.ai